Latest Posts
About This Stock
More About This Stock
Read
Read
A Quick Look At Recro Pharma
Article By:
KKD Healthcare Analytics
Sunday, January 22, 2017 12:07 PM EDT
Recro Pharma develops non-opioid drugs for pain management. REPH is targeting an NDA this year for its fast-acting IV version of Meloxicam, a well-known NSAID whose oral version just takes too long to work, but has been shown to be effective.
In this article: REPH
5 Best Performing Nasdaq Stocks Of 2015
Article By:
Zacks Investment Research
Monday, December 28, 2015 12:18 PM EDT
In the countdown to 2016, U.S. stocks look to end a lackluster year on a disappointing note. We’ve selected five top Nasdaq performers of 2015.
In this article: EFOI, LPTH, EGRX, HQCL, REPH Also: ALXN, AAPL, AMGN, AMZN, BIIB, GILD, INTC, MSFT, MYL, NFLX, PRGO, TEVA